Growth Metrics

BeOne Medicines (ONC) Finished Goods (2017 - 2025)

BeOne Medicines (ONC) has disclosed Finished Goods for 4 consecutive years, with $249.4 million as the latest value for Q4 2025.

  • On a quarterly basis, Finished Goods fell 5.65% to $249.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $249.4 million, a 5.65% decrease, with the full-year FY2025 number at $249.4 million, down 5.65% from a year prior.
  • Finished Goods was $249.4 million for Q4 2025 at BeOne Medicines, down from $264.3 million in the prior quarter.
  • In the past five years, Finished Goods ranged from a high of $264.3 million in Q4 2024 to a low of $249.4 million in Q4 2025.